Mon - Fri 10:00-18:00
Johannesburg, Fourways

Breakingviews – Corona Capital: Macquarie, Ray-Bans, Nivea, Oil

Reuters Reuters

HONG KONG/MILAN/LONDON (Reuters Breakingviews) – Corona Capital is a daily column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.


– Macquarie

– EssilorLuxottica

– Beiersdorf

– Total

LONG-TERM GREEDY. Macquarie’s boss is trying to see past the Covid-19 devastation. Shemara Wikramanayake opened the bank’s annual conference for Australian companies on Tuesday arguing that trends such as urbanisation, climate change and digitisation will drive demand for infrastructure, renewable energy and technology. And on the same day the government estimated that containment efforts are costing the economy $2.4 billion a week, she said the country can emerge from the crisis in good shape, partly thanks to many successful corporate capital calls.

Funnily enough, Macquarie gets paid to help issue equity and its business model hinges on financing roads, ports, wind farms and such. With the bank’s shares down by a third from their peak in February, it’s no wonder Wikramanayake wants to keep the focus beyond the virus horizon. Of course, just because she’s talking her book doesn’t mean she’s wrong. (By Jeffrey Goldfarb)

PANDEMIC THRIFT. EssilorLuxottica has rediscovered the value of saving in a crisis. Faced with a 10% revenue contraction in the first quarter, the world’s biggest maker of frames and optical lenses has cancelled dividends, buybacks and non-crucial investments. That’s smart if it wants to carry out a planned cash acquisition of optical retailer GrandVision while also coping with severe Covid-19 disruptions.

The 7 billion euro price tag, agreed in July last year, does not look cheap given the collapse in stock markets since then. And EssilorLuxottica said on Tuesday that it expects the second quarter to be even worse than the first. Its net debt of 4.8 billion euros, now comfortably just above 1 times EBITDA, could be pushed up to 3 times that measure by year end, says Morningstar. Luckily, the French-Italian group is sitting on a 4.9 billion euro liquidity pot and has pre-funded most of the GrandVision acquisition cost. Continuing to keep a lean profile in the crisis is the right approach. (By Lisa Jucca)

LIVIN’ ON A PRAIRIE. Beiersdorf’s investors are down on their luck. The maker of Nivea posted a 3.6% decline in first-quarter revenue to 1.9 billion euros, stripping out the impact of currency changes and mergers and acquisitions. Chief Executive Stefan De Loecker said he will stick with the company’s one-year-old investment programme but said little on its progress, suggesting he’s less than even halfway there.

The multi-year scheme was supposed to help Beiersdorf access new markets, and boost innovation, digitalisation and workforce training. But so far it’s failing to protect its brands. Sales of luxury skincare line La Prairie fell 36% because it couldn’t be sold in airports, lagging behind L’Oreal brands for which e-commerce strategies softened the blow. De Loecker is hoping to acquire some bargains in the crisis, but until he can show his investments are paying off, he’s better off just holding on to what he’s got. (By Dasha Afanasieva)

TOTAL’S HALFWAY HOUSE. After BP held its dividend and Royal Dutch Shell slashed its by two-thirds, the $87 billion French crude producer is giving investors the option to receive its fourth-quarter dividend for 2019 in shares. Assuming 60% go for it – as happened the last time so-called “scrip” was offered – it will add $1 billion to the group’s under-fire free cash flow.

While this may look like fence-sitting, it could make sense. Total is less leveraged than Shell and BP and has a big liquidity buffer. More importantly, oil prices have rallied from the start of May as analysts start to get slightly less pessimistic about a recovery in demand. Retaining the scope to extend the “scrip” further, or wind it down, might prove to have been a better strategy than BP’s inaction and Shell’s doom and gloom. (By George Hay)

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Leave a Reply

Select your currency
ZAR South African rand